CN102617643A - 一种核黄素磷酸钠化合物 - Google Patents
一种核黄素磷酸钠化合物 Download PDFInfo
- Publication number
- CN102617643A CN102617643A CN2012100581636A CN201210058163A CN102617643A CN 102617643 A CN102617643 A CN 102617643A CN 2012100581636 A CN2012100581636 A CN 2012100581636A CN 201210058163 A CN201210058163 A CN 201210058163A CN 102617643 A CN102617643 A CN 102617643A
- Authority
- CN
- China
- Prior art keywords
- riboflavin
- degrees
- anhydrous
- sodium phosphate
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229950001574 riboflavin phosphate Drugs 0.000 title claims abstract description 65
- -1 Riboflavin sodium phosphate compound Chemical class 0.000 title abstract description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 31
- 239000013078 crystal Substances 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 17
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910017488 Cu K Inorganic materials 0.000 claims abstract description 8
- 229910017541 Cu-K Inorganic materials 0.000 claims abstract description 8
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 claims description 33
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- 235000019192 riboflavin Nutrition 0.000 claims description 17
- 239000002151 riboflavin Substances 0.000 claims description 17
- 239000012046 mixed solvent Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 230000005260 alpha ray Effects 0.000 claims description 7
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 239000012065 filter cake Substances 0.000 claims description 7
- 239000006104 solid solution Substances 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 5
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 4
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 abstract description 60
- 238000002474 experimental method Methods 0.000 abstract description 6
- 238000012360 testing method Methods 0.000 description 24
- 238000000034 method Methods 0.000 description 13
- 239000000843 powder Substances 0.000 description 11
- 238000002425 crystallisation Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 238000004088 simulation Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000008558 metabolic pathway by substance Effects 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
溶解度(g/100ml) | |
实施例1 | 0.182 |
实施例1 | 0.180 |
实施例1 | 0.183 |
实施例1 | 0.182 |
对比药物 | 0.108 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210058163 CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210058163 CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102617643A true CN102617643A (zh) | 2012-08-01 |
CN102617643B CN102617643B (zh) | 2013-04-10 |
Family
ID=46557895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210058163 Active CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102617643B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104072540A (zh) * | 2014-05-22 | 2014-10-01 | 深圳朗欧医药集团有限公司 | 核黄素磷酸钠化合物及其制备方法 |
CN106674225A (zh) * | 2016-11-09 | 2017-05-17 | 珠海同源药业有限公司 | 一种核黄素磷酸钠化合物及其药物组合物 |
CN111094309A (zh) * | 2018-09-21 | 2020-05-01 | 邦泰生物工程(深圳)有限公司 | 高纯度核黄素磷酸钠的制备方法 |
CN114702524A (zh) * | 2022-04-29 | 2022-07-05 | 湖北广济药业股份有限公司 | 一种制备高纯度核黄素磷酸钠的方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU166356A1 (ru) * | 1961-12-15 | 1964-11-19 | Способ получения рибофлавип-5'-фосфата натрия | |
US4987229A (en) * | 1988-03-31 | 1991-01-22 | Basf Aktiengesellschaft | Purification of salts of riboflavin 5'-phosphate, in particular of monosodium riboflavin 5'-phosphate |
US5017700A (en) * | 1988-10-19 | 1991-05-21 | Basf Aktiengesellschaft | Preparation of riboflavin-5'-phosphate (5'-FMN) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate |
US5095115A (en) * | 1989-09-14 | 1992-03-10 | Basf Aktiengesellschaft | Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
EP0523582A1 (de) * | 1991-07-19 | 1993-01-20 | BASF Aktiengesellschaft | Verbessertes Verfahren zur Herstellung des Mononatriumsalzes von Riboflavin 5'-phosphat |
JPH1149790A (ja) * | 1997-06-05 | 1999-02-23 | Eisai Co Ltd | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 |
WO2003010172A1 (en) * | 2001-07-23 | 2003-02-06 | Eisai Co., Ltd. | Process for producing highly pure riboflavin-5’-phosphate sodium |
CN102206233A (zh) * | 2011-04-06 | 2011-10-05 | 湖北广济药业股份有限公司 | 核黄素磷酸酯钠的工业化制备方法 |
CN102260291A (zh) * | 2011-04-29 | 2011-11-30 | 周晓东 | 一种核黄素磷酸钠晶体化合物、其药物组合物及制备方法 |
-
2012
- 2012-03-06 CN CN 201210058163 patent/CN102617643B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU166356A1 (ru) * | 1961-12-15 | 1964-11-19 | Способ получения рибофлавип-5'-фосфата натрия | |
US4987229A (en) * | 1988-03-31 | 1991-01-22 | Basf Aktiengesellschaft | Purification of salts of riboflavin 5'-phosphate, in particular of monosodium riboflavin 5'-phosphate |
US5017700A (en) * | 1988-10-19 | 1991-05-21 | Basf Aktiengesellschaft | Preparation of riboflavin-5'-phosphate (5'-FMN) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate |
US5095115A (en) * | 1989-09-14 | 1992-03-10 | Basf Aktiengesellschaft | Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
EP0523582A1 (de) * | 1991-07-19 | 1993-01-20 | BASF Aktiengesellschaft | Verbessertes Verfahren zur Herstellung des Mononatriumsalzes von Riboflavin 5'-phosphat |
JPH1149790A (ja) * | 1997-06-05 | 1999-02-23 | Eisai Co Ltd | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 |
WO2003010172A1 (en) * | 2001-07-23 | 2003-02-06 | Eisai Co., Ltd. | Process for producing highly pure riboflavin-5’-phosphate sodium |
CN102206233A (zh) * | 2011-04-06 | 2011-10-05 | 湖北广济药业股份有限公司 | 核黄素磷酸酯钠的工业化制备方法 |
CN102260291A (zh) * | 2011-04-29 | 2011-11-30 | 周晓东 | 一种核黄素磷酸钠晶体化合物、其药物组合物及制备方法 |
Non-Patent Citations (4)
Title |
---|
《中国食品添加剂》 20111231 魏转等 "利用核黄素粗品制备核黄素5"-磷酸钠" 第49-55页 1-8 , 第06期 * |
《食品科学》 20081231 孙文敬等 "核黄素磷酸钠生产工艺的研究" 第188-190页 1-8 第29卷, 第8期 * |
孙文敬等: ""核黄素磷酸钠生产工艺的研究"", 《食品科学》 * |
魏转等: ""利用核黄素粗品制备核黄素5"-磷酸钠"", 《中国食品添加剂》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104072540A (zh) * | 2014-05-22 | 2014-10-01 | 深圳朗欧医药集团有限公司 | 核黄素磷酸钠化合物及其制备方法 |
CN104072540B (zh) * | 2014-05-22 | 2016-08-17 | 深圳朗欧医药集团有限公司 | 核黄素磷酸钠化合物及其制备方法 |
CN106674225A (zh) * | 2016-11-09 | 2017-05-17 | 珠海同源药业有限公司 | 一种核黄素磷酸钠化合物及其药物组合物 |
CN111094309A (zh) * | 2018-09-21 | 2020-05-01 | 邦泰生物工程(深圳)有限公司 | 高纯度核黄素磷酸钠的制备方法 |
CN114702524A (zh) * | 2022-04-29 | 2022-07-05 | 湖北广济药业股份有限公司 | 一种制备高纯度核黄素磷酸钠的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102617643B (zh) | 2013-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102617643B (zh) | 一种核黄素磷酸钠化合物 | |
CN103768091A (zh) | 碳酸氢钠注射液及其制备方法 | |
CN101829118A (zh) | 头孢孟多酯钠组合物粉针 | |
CN103054797B (zh) | 一种泮托拉唑钠的药物组合物及其制备方法 | |
CN101912365B (zh) | 一种注射用磺苄西林钠粉针及其制备工艺 | |
CN101297809A (zh) | 头孢哌酮钠与舒巴坦钠混粉的制备方法 | |
CN102367229B (zh) | 一种二乙酰氨乙酸乙二胺化合物及其药物组合物 | |
CN114028346B (zh) | 注射用奥美拉唑钠及其制备方法 | |
CN102260291B (zh) | 一种核黄素磷酸钠化合物及其制备 | |
CN103145736A (zh) | 一种含有头孢孟多酯钠化合物的药物组合物 | |
CN102727451B (zh) | 一种含有头孢美唑钠的药物组合物 | |
CN113081975B (zh) | 注射用克林霉素磷酸酯冻干粉针剂的制备方法 | |
CN105520942A (zh) | 一种氨苄西林钠舒巴坦钠的药物组合物 | |
CN106456792B (zh) | 制备含厄他培南的冻干制剂的方法 | |
CN102716075B (zh) | 一种含有头孢唑肟钠的药物组合物 | |
CN110251461B (zh) | 复合维生素b注射液及其制备方法 | |
CN103304604B (zh) | 一种克林霉素磷酸酯化合物,其制备方法及其药物组合物 | |
CN106866631A (zh) | 一种右旋兰索拉唑晶型及制备方法 | |
CN111909180A (zh) | 稳定性好、可操作化高的头孢曲松钠晶体的制备方法 | |
CN113230216B (zh) | 一种注射用吡拉西坦冻干粉针剂及其制备方法 | |
CN104761463B (zh) | D‑泛酸钠晶体及其制备方法和用途 | |
CN110314143A (zh) | 注射用右旋奥拉西坦冻干制剂及其制备方法 | |
CN101691371B (zh) | 培美曲塞硫脲盐及其制备方法 | |
CN109535182B (zh) | 一种头孢西酮钠的制备方法 | |
CN114159432B (zh) | 一种替卡西林钠克拉维酸钾药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120801 Assignee: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. Assignor: Huang Jinxiu Contract record no.: 2013440000331 Denomination of invention: Riboflavin sodium phosphate compound and composition thereof Granted publication date: 20130410 License type: Exclusive License Record date: 20130708 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20151204 Contract record no.: 2013440000331 Assignee after: Zhuhai homologous Pharmaceutical Co., Ltd. Assignee before: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180104 Address after: 519015 Guangdong city of Zhuhai province Jida West No. 209 Peace Industrial Center Building 2 floor Patentee after: Zhuhai morning Ann Pharmaceutical Co., Ltd. Address before: 519020 Guangdong city of Zhuhai province Jida West No. 209 Peace Industrial Center Building 2 floor Patentee before: Huang Jinxiu |
|
TR01 | Transfer of patent right | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20180329 Contract record no.: 2013440000331 Assignor after: Zhuhai morning Ann Pharmaceutical Co., Ltd. Assignor before: Huang Jinxiu |
|
EM01 | Change of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: ZHUHAI TONGYUAN PHARMACEUTICAL Co.,Ltd. Assignor: Zhuhai morning Ann Pharmaceutical Co.,Ltd. Contract record no.: 2013440000331 Date of cancellation: 20200610 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120801 Assignee: ZHUHAI TONGYUAN PHARMACEUTICAL Co.,Ltd. Assignor: Zhuhai morning Ann Pharmaceutical Co.,Ltd. Contract record no.: X2020440000096 Denomination of invention: Riboflavin sodium phosphate compound and composition thereof Granted publication date: 20130410 License type: Exclusive License Record date: 20200622 |
|
EE01 | Entry into force of recordation of patent licensing contract |